Search Results
Nov 10, 2025, 06:30 ET Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
Therapeutics ("Keenova" or the "Company") and will focus on developing, manufacturing, and commercializing branded therapeutics that help patients with rare or unaddressed conditions live happier and healthier lives.
More news about: Keenova Therapeutics
Nov 10, 2025, 05:25 ET Precious Metals Market Set to Reach USD 386.16B by 2030, Backed by Rising Industrial Demand and Safe-Haven Investments, Says Mordor Intelligence
related reports published by Mordor Intelligence: Rare Earth Metals Market: The rare earth metals market is categorized by product type (light and heavy rare earth elements), element (such as cerium, neodymium, and others), application (including catalysts,
More news about: Mordor Intelligence Private Limited
Nov 10, 2025, 03:48 ET Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL
programs across liver, muscle, the brain, where we're actively working on curing genetic diseases using this method of changing the DNA. We've started with rare diseases, but there's no reason that we have to stop there. Imagine how many millions of lives this could save." Neurotech
More news about: GITEX
Nov 10, 2025, 03:39 ET Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL
programs across liver, muscle, the brain, where we're actively working on curing genetic diseases using this method of changing the DNA. We've started with rare diseases, but there's no reason that we have to stop there. Imagine how many millions of lives this could save." Neurotech
More news about: GITEX
Nov 10, 2025, 02:20 ET Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA
-- Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced the submission of the clinical trial protocol for the planned global Phase IIb trial of its lead
More news about: Cereno Scientific
Nov 10, 2025, 02:16 ET Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA
-- Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced the submission of the clinical trial protocol for the planned global Phase IIb trial of its lead
More news about: Cereno Scientific
Nov 09, 2025, 21:00 ET One Event. Multiple Ways to Grow Your Wealth.
Attending Exclusive Portfolio Reveals Get a rare look at each speaker's actual 2025 portfolio performance — the trades, wins, and lessons that shaped their year.Discover what truly worked,
More news about: Next Level Academy
Nov 09, 2025, 06:30 ET Kyphosis Solution: Forme® Recognized for Smart Corrective Clothing by Expert Consumers
learning, and digital lifestyles have intensified the strain on spinal health, especially among younger generations. Conditions like flexible kyphosis, once rare in teenagers, are now appearing earlier and more frequently. Forme® provides a timely and practical response to this issue. Its
More news about: ExpertConsumers.org
Nov 09, 2025, 03:00 ET Première thérapie mondiale d'édition génique ciblant l'APOC3 pour le traitement de l'hyperlipidémie
familiale et le syndrome de chylomicronémie multifactorielle. Le syndrome de chylomicronémie familiale est une maladie autosomique récessive rare causée par des mutations bialléliques du gène de la lipoprotéine lipase (LPL) ou d'autres gènes régulateurs clés, avec des TG à jeun ≥ 10 mmol/L (885 mg/dL)
More news about: CorrectSequence Therapeutics
Nov 08, 2025, 20:48 ET Botulism Alert: ByHeart-brand infant formula linked to 13 illnesses in 10 States
major retailers nationwide. What is Botulism Botulism is a rare, life-threatening paralytic illness caused by neurotoxins produced by an anaerobic, gram-positive, spore-forming bacterium, Clostridium botulinum. The
More news about: Marler Clark, The Food Safety Law Firm
Nov 08, 2025, 10:40 ET Clinically meaningful pivotal study results for olezarsen in sHTG presented as a late breaker at AHA Scientific Sessions
Sobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Nov 08, 2025, 10:15 ET AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best
More news about: Amgen
Nov 07, 2025, 20:58 ET The Future of Longevity and Wellness Investment to Be Highlighted at This Year's Global Wellness Summit in Dubai
outline how strategic investment is evolving across wellness real estate, hospitality, longevity science and tech-enabled wellbeing—offering delegates a rare glimpse into where the smart money is flowing and what defines a truly investable concept in 2025 and beyond.
More news about: Global Wellness Summit
Nov 07, 2025, 19:29 ET U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
In the U.S., KYGEVVI received Orphan Drug, Breakthrough, Priority Review and Rare Pediatric Disease designations from the FDA.12,13 With this approval by FDA, UCB was awarded a Rare Pediatric Disease Priority Review Voucher (RPDPRV) redeemable for a priority review for a future
More news about: UCB
Nov 07, 2025, 17:14 ET Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS® in HER2 lung cancer
patients as quickly as possible." This recognition underscores the potential of HERNEXEOS to meet critical patient needs for this rare and aggressive cancer. HER2 (ERRB2) mutations are found in approximately 2-4% of NSCLC cases and are linked to poor prognosis.1 The estimated
More news about: Boehringer Ingelheim
Nov 07, 2025, 15:17 ET Forest Investment Associates Highlights $220 Million Georgia/Alabama Timberland Acquisition
standards. The acquisition includes the 931-acre Coosa Valley Prairie, protected under a conservation easement with The Nature Conservancy, preserving rare habitat within a working forest. About Forest Investment Associates Forest
More news about: Forest Investment Associates
Nov 07, 2025, 14:08 ET Bellagio and Major Food Group Unveil CARBONE RIVIERA, Ushering in a New Era of Fine Dining on the Las Vegas Strip
-YACHT Docked on the patio at CARBONE RIVIERA, Fortuna, Bellagio's custom 33-foot Riva yacht, offers invited guests a rare and unforgettable way to experience the iconic Fountains. One of only 18 in the world, Fortuna is part of the limited-edition Riva "Anniversario"
More news about: MGM Resorts International
Nov 07, 2025, 12:16 ET Aris Investing Appoints Industry Veteran Monisha Jayakumar as Chief Investment Officer
also oversee the firm's tax-efficient portfolio management and the continued expansion of its tax overlay capabilities. "Monisha brings a rare combination of systematic expertise and client-centered thinking," said Chetan Desai, CEO of Aris Investing. "Her ability to turn complex
More news about: Aris Investing
Nov 07, 2025, 11:00 ET The U.S. National Park You've Never Heard Of Now Just a Click Away
makes our hidden gem just a little easier to find. We're not a Sheraton or Hilton kind of destination; this is a place for curious travelers who want a rare window into a traditional way of life that still honors its language, customs, and people." Set in the heart of Polynesia, American
More news about: South Pacific Pocket Guide
Nov 07, 2025, 10:54 ET Mega Millions® jackpot hits $843 million - first major run under new rules drives unprecedented demand
billion jackpot in September 2025, the second-largest in U.S. history. Back-to-back jackpot runs of this magnitude are exceedingly rare, underscoring a landmark year for American lotteries and a new phase of digital adoption. How to Play
More news about: Jackpot.com
Nov 07, 2025, 10:18 ET Project InnerSpace Among Top Five Climate Nonprofits for 2025
think that is something to really celebrate. Amongst unprecedented polarization we can agree to move forward together on this energy solution - what a rare and awesome opportunity - and we are so fired up to lead that charge." If you are interested in becoming a partner through a
More news about: Project InnerSpace
Nov 07, 2025, 10:04 ET Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
once-daily oral tablet intended to treat hyperphagia. Soleno has described this condition as "the most life-limiting aspect" of Prader-Willi syndrome, a rare genetic disorder that causes physical, mental, and behavioral problems.
More news about: Hagens Berman Sobol Shapiro LLP
Nov 07, 2025, 10:00 ET Gray Honors the Legacy of Howard Gray, Visionary Leader and Builder of People
nurtured with care and integrity. He often quoted his friend and advisor Maurice Mascarenhas: "Relationships are like fine chinaware; costly, rich, and rare. Once broken, they can be mended, but the crack is always there." He would always add: "Never let it break!" He also
More news about: Gray Construction
Nov 07, 2025, 09:42 ET Maneesh K. Goyal Appointed President and Executive Chairman of Interluxe Group
such as Google, Delta Air Lines, and Warby Parker. He is also the owner of the acclaimed New York restaurants Passerine and Temple Bar. Goyal brings a rare blend of entrepreneurial vision, operational discipline, and a deep understanding of integrated marketing campaigns across experiential, digital activation,
More news about: North & Warren
Nov 07, 2025, 09:38 ET MUSEUM OF SEX DEBUTS UTOPIA: THREE CENTURIES OF SEXUALITY IN AMERICAN CULTS AND COMMUNES, A LANDMARK EXHIBITION CURATED BY JODI WILLE
communities, the show brings together an unprecedented display of more than 300 artworks, photographs, films, records, printed matter, clothing and rare artifacts to explore how sexuality and communal life shaped alternative visions of society and influenced the larger culture. Utopia reframes
More news about: Museum of Sex